Major study uncovers 'hidden pandemic' of lung complications after surgery (opens original article in a new tab)
A major study found that 19% of patients given sugammadex experienced post-operative lung complications compared to 21.5% with neostigmine, highlighting a significant 'hidden pandemic' of respiratory issues after surgery.
- A major international study found 19% of patients given sugammadex had post-operative lung complications vs 21.5% with neostigmine
- Researchers identified a 'hidden pandemic' of lung issues after surgery, including pneumonia and atelectasis
- The study involved 3,500 patients across 44 hospitals in Australia, New Zealand, and Hong Kong
- Sugammadex was associated with reduced atelectasis but remains more expensive and less accessible in some regions
Conversation
No comments yet
Threaded discussion is coming next — this is where the community conversation about this story will live.